These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30873608)

  • 21. Mutation screening of the neurexin 1 gene in thai patients with intellectual disability and autism spectrum disorder.
    Yangngam S; Plong-On O; Sripo T; Roongpraiwan R; Hansakunachai T; Wirojanan J; Sombuntham T; Ruangdaraganon N; Limprasert P
    Genet Test Mol Biomarkers; 2014 Jul; 18(7):510-5. PubMed ID: 24832020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two rare deletions upstream of the NRXN1 gene (2p16.3) affecting the non-coding mRNA AK127244 segregate with diverse psychopathological phenotypes in a family.
    Duong LT; Hoeffding LK; Petersen KB; Knudsen CD; Thygesen JH; Klitten LL; Tommerup N; Ingason A; Werge T
    Eur J Med Genet; 2015 Dec; 58(12):650-3. PubMed ID: 26563496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders.
    Duong L; Klitten LL; Møller RS; Ingason A; Jakobsen KD; Skjødt C; Didriksen M; Hjalgrim H; Werge T; Tommerup N
    Am J Med Genet B Neuropsychiatr Genet; 2012 Apr; 159B(3):354-8. PubMed ID: 22337556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unraveling Mechanisms of Patient-Specific NRXN1 Mutations in Neuropsychiatric Diseases Using Human Induced Pluripotent Stem Cells.
    De Los Angeles A; Tunbridge EM
    Stem Cells Dev; 2020 Sep; 29(17):1142-1144. PubMed ID: 32122280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.
    Ching MS; Shen Y; Tan WH; Jeste SS; Morrow EM; Chen X; Mukaddes NM; Yoo SY; Hanson E; Hundley R; Austin C; Becker RE; Berry GT; Driscoll K; Engle EC; Friedman S; Gusella JF; Hisama FM; Irons MB; Lafiosca T; LeClair E; Miller DT; Neessen M; Picker JD; Rappaport L; Rooney CM; Sarco DP; Stoler JM; Walsh CA; Wolff RR; Zhang T; Nasir RH; Wu BL;
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jun; 153B(4):937-47. PubMed ID: 20468056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single cell analysis of autism patient with bi-allelic NRXN1-alpha deletion reveals skewed fate choice in neural progenitors and impaired neuronal functionality.
    Lam M; Moslem M; Bryois J; Pronk RJ; Uhlin E; Ellström ID; Laan L; Olive J; Morse R; Rönnholm H; Louhivuori L; Korol SV; Dahl N; Uhlén P; Anderlid BM; Kele M; Sullivan PF; Falk A
    Exp Cell Res; 2019 Oct; 383(1):111469. PubMed ID: 31302032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incomplete penetrance of NRXN1 deletions in families with schizophrenia.
    Todarello G; Feng N; Kolachana BS; Li C; Vakkalanka R; Bertolino A; Weinberger DR; Straub RE
    Schizophr Res; 2014 May; 155(1-3):1-7. PubMed ID: 24680031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series - further understanding of the relevance of NRXN1 to neurodevelopmental disorders.
    Curran S; Ahn JW; Grayton H; Collier DA; Ogilvie CM
    J Mol Psychiatry; 2013; 1(1):4. PubMed ID: 25408897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NRXN1 Deletion in Two Twins' Genotype and Phenotype: A Clinical Case and Literature Review.
    Sciacca M; Marino L; Vitaliti G; Falsaperla R; Marino S
    Children (Basel); 2022 May; 9(5):. PubMed ID: 35626875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fraternal twins with autism, severe cognitive deficit, and epilepsy: diagnostic role of chromosomal microarray analysis.
    Imitola J; Walleigh D; Anderson CE; Jethva R; Carvalho KS; Legido A; Khurana DS
    Semin Pediatr Neurol; 2014 Jun; 21(2):167-71. PubMed ID: 25149956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence analysis of 17 NRXN1 deletions.
    Enggaard Hoeffding LK; Hansen T; Ingason A; Doung L; Thygesen JH; Møller RS; Tommerup N; Kirov G; Rujescu D; Larsen LA; Werge T
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):52-61. PubMed ID: 24339137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of a deletion hotspot in the NRXN1 region reveals the involvement of short inverted repeats in deletion CNVs.
    Chen X; Shen Y; Zhang F; Chiang C; Pillalamarri V; Blumenthal I; Talkowski M; Wu BL; Gusella JF
    Am J Hum Genet; 2013 Mar; 92(3):375-86. PubMed ID: 23472757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia.
    Ishizuka K; Yoshida T; Kawabata T; Imai A; Mori H; Kimura H; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Morikawa M; Okada T; Ikeda M; Branko A; Mori D; Someya T; Iwata N; Ozaki N
    J Neurodev Disord; 2020 Sep; 12(1):25. PubMed ID: 32942984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1.
    Pak C; Danko T; Zhang Y; Aoto J; Anderson G; Maxeiner S; Yi F; Wernig M; Südhof TC
    Cell Stem Cell; 2015 Sep; 17(3):316-28. PubMed ID: 26279266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes.
    Mozhui K; Wang X; Chen J; Mulligan MK; Li Z; Ingles J; Chen X; Lu L; Williams RW
    Transl Psychiatry; 2011 Jul; 1(7):e25. PubMed ID: 22832527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compound heterozygous deletion of NRXN1 causing severe developmental delay with early onset epilepsy in two sisters.
    Harrison V; Connell L; Hayesmoore J; McParland J; Pike MG; Blair E
    Am J Med Genet A; 2011 Nov; 155A(11):2826-31. PubMed ID: 21964664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
    Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
    PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy.
    Møller RS; Weber YG; Klitten LL; Trucks H; Muhle H; Kunz WS; Mefford HC; Franke A; Kautza M; Wolf P; Dennig D; Schreiber S; Rückert IM; Wichmann HE; Ernst JP; Schurmann C; Grabe HJ; Tommerup N; Stephani U; Lerche H; Hjalgrim H; Helbig I; Sander T;
    Epilepsia; 2013 Feb; 54(2):256-64. PubMed ID: 23294455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of the NRXN1 gene in a Chinese autism cohort.
    Liu Y; Hu Z; Xun G; Peng Y; Lu L; Xu X; Xiong Z; Xia L; Liu D; Li W; Zhao J; Xia K
    J Psychiatr Res; 2012 May; 46(5):630-4. PubMed ID: 22405623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A de novo microdeletion in NRXN1 in a Dutch patient with mild intellectual disability, microcephaly and gonadal dysgenesis.
    Agha Z; Iqbal Z; Kleefstra T; Zweier C; Pfundt R; Qamar R; VAN Bokhoven H; Willemsen MH
    Genet Res (Camb); 2015 Oct; 97():e19. PubMed ID: 26438105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.